𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glycolysis Back in the Limelight: Systemic Targeting of HK2 Blocks Tumor Growth

✍ Scribed by Ros, S.; Schulze, A.

Book ID
121352324
Publisher
American Association for Cancer Research
Year
2013
Tongue
English
Weight
440 KB
Volume
3
Category
Article
ISSN
2159-8274

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Transforming growth factor-Ξ²1 blocks the
Transforming growth factor-Ξ²1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts
✍ Nan-Shan Chang πŸ“‚ Article πŸ“… 2002 πŸ› BioMed Central 🌐 English βš– 874 KB

Background: Functional antagonism between transforming growth factor beta (TGF-Ξ²) and hyaluronidase has been demonstrated. For example, testicular hyaluronidase PH-20 counteracts TGF-Ξ²1-mediated growth inhibition of epithelial cells. PH-20 sensitizes various cancer cells to tumor necrosis factor (TN

Targeting the IGF-1R using picropodophyl
Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: Beneficial effects on tumor growth, angiogenesis, bone disease and survival
✍ Eline Menu; Helena Jernberg-Wiklund; Hendrik De Raeve; Evy De Leenheer; Les Coul πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 267 KB πŸ‘ 1 views

## Abstract During the last decade, a central role for insulin‐like growth factor 1 (IGF‐1) in the pathophysiology of multiple myeloma (MM) has been well established. IGF‐I provided by the tumor–microenvironment interaction may directly and indirectly facilitate the migration, survival and expansio